These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2901127)

  • 1. Single-dose kinetics of the neuroleptic drug perazine in psychotic patients.
    Breyer-Pfaff U; Nill K; Schied HW; Gaertner HJ; Giedke H
    Psychopharmacology (Berl); 1988; 95(3):374-7. PubMed ID: 2901127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of amitriptyline and imipramine on the pharmacokinetics and metabolism of perazine in rats.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2000 Dec; 52(12):1473-81. PubMed ID: 11197075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early serum levels of neuroleptics do not predict therapeutic response in schizophrenia.
    Gaebel W; Müller-Oerlinghausen B; Schley J
    Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):891-900. PubMed ID: 1355303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution interactions between perazine and antidepressant drugs. In vivo studies.
    Wójcikowski J; Daniel WA
    Pol J Pharmacol; 2000; 52(6):449-57. PubMed ID: 11334238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal trapping as an important mechanism involved in the cellular distribution of perazine and in pharmacokinetic interaction with antidepressants.
    Daniel WA; Wójcikowski J
    Eur Neuropsychopharmacol; 1999 Dec; 9(6):483-91. PubMed ID: 10625116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in drug elimination under the influence of perazine therapy (author's transl)].
    Petruch F; Schüppel R; Breyer U
    Arzneimittelforschung; 1976; 26(6):1154-5. PubMed ID: 9113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction and evaluation criteria in perazine therapy of acute schizophrenics. Pharmacokinetic data.
    Breyer-Pfaff U; Brinkschulte M; Rein W; Schied HW; Straube E
    Pharmacopsychiatria; 1983 Sep; 16(5):160-5. PubMed ID: 6140695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.
    Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
    Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P-450 enzymes and FMO3 contribute to the disposition of the antipsychotic drug perazine in vitro.
    Störmer E; Brockmöller J; Roots I; Schmider J
    Psychopharmacology (Berl); 2000 Sep; 151(4):312-20. PubMed ID: 11026737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
    Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
    Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliable routine method for determination of perazine in serum by thin-layer chromatography with an internal standard.
    Kresse M; Schley J; Müller-Oerlinghausen B
    J Chromatogr; 1980 Oct; 183(4):475-82. PubMed ID: 6107303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perazine in the treatment of psychotic disorders--research review].
    Kiejna A
    Psychiatr Pol; 2010; 44(3):427-34. PubMed ID: 20672521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicide with moclobemide and perazine.
    Musshoff F; Varchmin-Schultheiss K; Madea B
    Int J Legal Med; 1998; 111(4):196-8. PubMed ID: 9646163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolism and excretion of the neuroleptic drug perazine in healthy volunteers].
    Schley J; Riedel E; Müller-Oerlinghausen B
    Int Pharmacopsychiatry; 1981; 16(4):201-11. PubMed ID: 6121765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fatal poisoning with clozapine and perazine. A case report].
    Ganssmann B; Skopp G; Aderjan R; Mattern R
    Arch Kriminol; 1998; 201(1-2):11-20. PubMed ID: 9541713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction and evaluation criteria in perazine therapy of acute schizophrenics. Methodological considerations, sample population, and research variables.
    Rein W; Schied HW; Breyer-Pfaff U; Straube E
    Pharmacopsychiatria; 1983 Sep; 16(5):147-51. PubMed ID: 6140693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of serum bioactivity levels of perazine and its metabolites by radioreceptor assay.
    Rao ML
    Pharmacopsychiatry; 1989 May; 22(3):104-7. PubMed ID: 2568642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thin-layer and gas-liquid chromatographic procedures for the determination of perazine and its metabolites in human body fluids.
    Müller-Oerlinghausen B; Riedel E; Schley J
    Int J Clin Pharmacol Biopharm; 1977 Aug; 15(8):366-72. PubMed ID: 19364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of perazine serum levels by gas liquid chromatography under clinical routine conditions.
    Schley J; Riedel E; Müller-Oerlinghausen B
    J Clin Chem Clin Biochem; 1978 May; 16(5):307-11. PubMed ID: 27569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.